A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics

Despite the growing threat of antimicrobial resistance, pharmaceutical and biotechnology firms are reluctant to develop novel antibiotics because of a host of market failures. This problem is complicated by public health goals that demand antibiotic conservation and equitable patient access. Thus, a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antibiotics 2016-02, Vol.69 (2), p.73-88
Main Authors: Renwick, Matthew J, Brogan, David M, Mossialos, Elias
Format: Article
Language:English
Subjects:
692/308/153
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - isolation & purification
Anti-Bacterial Agents - pharmacology
Antibiotics
Bacteriology
Biomedical and Life Sciences
Bioorganic Chemistry
Biotechnology
Decision Support Techniques
Drug Discovery - methods
Drug Discovery - trends
Global Health
Health Policy
Humans
Life Sciences
Medicinal Chemistry
Microbiology
Motivation
Organic Chemistry
Public health
Review
review-article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!